Show
Sort by
-
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma
-
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
-
Argx-110 for treatment of CD70-positive advanced cutaneous T-cell lymphoma in a phase 1/2 clinical trial
-
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies
-
- Journal Article
- A1
- open access
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy
-
Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling
-
- Journal Article
- A1
- open access
Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice
-
- Journal Article
- A1
- open access
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules
-
- Journal Article
- A1
- open access
Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection
-
Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion